Financials
- Market Capitalization 10.72 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
33.02
市销率
3.64
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 848 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 467.16 USD | -0.97% | -6.02% | -13.49% | +10.28% | 10.79 B USD | ||
| 851 | IBRX ImmunityBio, Inc. - Common Stock | 10.12 USD | -3.71% | -1.27% | +28.26% | +316.46% | 10.73 B USD | ||
| 868 | PCVX Vaxcyte, Inc. - Common Stock | 70.65 USD | -1.02% | -3.68% | +17.67% | +67.02% | 10.51 B USD | ||
| 892 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.24 USD | -0.68% | +4.26% | +1.73% | +99.87% | 10.08 B USD |